Heart Test Laboratories (NASDAQ:HSCS – Get Free Report) and Avitar (OTCMKTS:AVTI – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, profitability and valuation.
Analyst Recommendations
This is a summary of recent ratings and price targets for Heart Test Laboratories and Avitar, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Heart Test Laboratories | 0 | 0 | 2 | 0 | 3.00 |
Avitar | 0 | 0 | 0 | 0 | 0.00 |
Heart Test Laboratories presently has a consensus price target of $13.50, indicating a potential upside of 297.06%. Given Heart Test Laboratories’ stronger consensus rating and higher possible upside, equities analysts plainly believe Heart Test Laboratories is more favorable than Avitar.
Volatility & Risk
Earnings and Valuation
This table compares Heart Test Laboratories and Avitar”s top-line revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Heart Test Laboratories | $14,700.00 | 226.67 | -$6.61 million | ($7.91) | -0.43 |
Avitar | N/A | N/A | N/A | N/A | N/A |
Avitar has lower revenue, but higher earnings than Heart Test Laboratories.
Profitability
This table compares Heart Test Laboratories and Avitar’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Heart Test Laboratories | N/A | -144.12% | -94.48% |
Avitar | N/A | N/A | N/A |
Institutional & Insider Ownership
17.2% of Heart Test Laboratories shares are owned by institutional investors. 1.8% of Heart Test Laboratories shares are owned by insiders. Comparatively, 7.4% of Avitar shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Summary
Heart Test Laboratories beats Avitar on 6 of the 9 factors compared between the two stocks.
About Heart Test Laboratories
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
About Avitar
Avitar, Inc. is a holding company which through its subsidiaries designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine such as crack; marijuana; and methamphetamines, including meth and ecstasy. The company also provides foam disposable products including medical-grade hydrophilic polyurethane foam disposables such as wound dressings comprising Hydrasorb, a wound dressing product for exudating wounds; and various custom foam products comprising a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit. In addition, it develops specialty wound dressings for the cardiac catheter lab market, as well as the Illizarov Dressing used for dressing external bone fixators in orthopedic procedures. The company markets its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies, schools, and corporations through direct sales force and strategic partners, as well as through a network of distributors. Avitar, Inc. was founded in 1986 and is based in Canton, Massachusetts with Additional office in Calgary, Canada.
Receive News & Ratings for Heart Test Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heart Test Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.